Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients
about
Genetic background in nonalcoholic fatty liver disease: A comprehensive reviewThe C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?Genotype Phenotype Correlation of Genetic Polymorphism of PPAR Gamma Gene and Therapeutic Response to Pioglitazone in Type 2 Diabetes Mellitus- A Pilot StudyThe Wide and Complex Field of NAFLD Biomarker Research: Trends.The role of TGF-β1 869 T > C and PPAR γ2 34 C > G polymorphisms, fat mass, and anthropometric characteristics in predicting childhood obesity at birth: A cross-sectional study according the parental characteristics and newborn's risk for child obesiGenetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD.Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.Update on pparγ and nonalcoholic Fatty liver disease.
P2860
Q26780248-FC9290ED-1D3D-4F03-B1D3-19D34616E0B3Q34019843-EBA6FBA5-AF6C-4DC3-9592-87A9A8A9C366Q36253614-9B8E54A3-AE99-4246-94F1-73B55CF76063Q36619149-1E59B423-F2AA-4124-9923-5641300BB9F7Q36708512-932040F1-8952-40D6-B8AB-167BCA9712F3Q36962085-D19A5381-052F-4A52-9023-5E7BA1EE2E6DQ37605461-F00596DA-671E-4A5E-BF1D-C442DBF12EF7Q38406519-D41B95E8-42CD-4BCB-ABAA-9387D1D19090Q39177106-475D37DD-77E0-46CA-B45A-7141A2EDC1FDQ39229702-03B335A6-1EBC-4B58-892E-198BE11AB064Q41903480-0BEEC94B-8022-4EB5-9476-376954D374FD
P2860
Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Peroxisome proliferators-activ ...... c fatty liver disease patients
@en
Peroxisome proliferators-activ ...... c fatty liver disease patients
@nl
type
label
Peroxisome proliferators-activ ...... c fatty liver disease patients
@en
Peroxisome proliferators-activ ...... c fatty liver disease patients
@nl
prefLabel
Peroxisome proliferators-activ ...... c fatty liver disease patients
@en
Peroxisome proliferators-activ ...... c fatty liver disease patients
@nl
P2093
P2860
P1476
Peroxisome proliferators-activ ...... c fatty liver disease patients
@en
P2093
A K Chaudhory
P2860
P2888
P304
P356
10.1007/S12072-010-9225-Z
P577
2010-12-01T00:00:00Z